Global Oncology Drugs Industry 2013-2018: Trend, Profit, and - PowerPoint PPT Presentation

global oncology drugs industry 2013 2018 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Global Oncology Drugs Industry 2013-2018: Trend, Profit, and PowerPoint Presentation
Download Presentation
Global Oncology Drugs Industry 2013-2018: Trend, Profit, and

play fullscreen
1 / 7
Global Oncology Drugs Industry 2013-2018: Trend, Profit, and
125 Views
Download Presentation
bharatbookseo
Download Presentation

Global Oncology Drugs Industry 2013-2018: Trend, Profit, and

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Global Oncology Drugs Industry 2013-2018 Bharat Book Bureau

  2. Summary The global oncology drugs industry experienced significant growth during the past five years and is expected to continue that momentum to reach an estimated $100.6 billion in 2018.A leading global management consulting and market research firm, has analyzed the global oncology drugs industry and presents its findings in “Global Oncology Drugs Industry 2013-2018: Trend, Profit, and Forecast Analysis.” The industry comprises firms primarily engaged in the development, manufacture, and marketing of oncology drugs.This study of the oncology drugs industry includes all classes of drugs that are used as an anti-cancer drug for the treatment of cancer such as lung cancer, mouth cancer, colorectal cancer, skin cancer, kidney cancer, and all such other types of cancer, which are marketed and distributed as an oncology drugs.

  3. Continue… North America dominates this industry with more than one-third of the market share. Roche Holding Ltd., Novartis AG, Astra Zeneca Plc, Eli Lilly & Co., and Sanofi SA are the major industry players. A combination of factors such as technology innovations, medical insurance coverage, aging population, and changing lifestyles are seen to affect market dynamics significantly. The industry has seen a number of recent changes including growing competition, rise in merger and acquisition activities, increased cancer health insurance coverage, and an increasing amount of foreign direct investment.

  4. Table of Contents 1. Executive Summary2. Industry Definition and Scope3. Industry Overview4. Global Macroeconomic Overview5. Industry Trends6. Industry Forecasts7. Emerging Trends8. ConclusionsList of FiguresChapter 3. Industry OverviewFigure 3.1: External forces shaping global oncology drugs industry

  5. Related Reports • Light Sciences Oncology, Inc. - Product Pipeline Review - 2013 • Neogenix Oncology, Inc. - Product Pipeline Analysis • Neogenix Oncology, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile • Champions Oncology, Inc. (CSBR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  6. About us : Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

  7. For More Information You Can Visit- http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/global-oncology-drugs-industry-2013-2018-trend-profit-and-forecast-analysis.htmlOr visit us at: Bharat Book Bureau Phone : +91 22 27810772, 27810773 Call UK: +44 7405 208461 Toll Free No for USA/Canada : 1-866-279-8368 E-mail : info@bharatbook.com Website : www.bharatbook.com Follow us on : Request Sample Pages